In the Fall 2022 semester, Fordham University undergraduates completing professor Lindsay Hoyt’s Adolescents in Research and Policy course had the opportunity to work directly with All Hallows ...

Last November, results from the MITIGATE trial made headlines at ACR Convergence 2024 with positive phase 3 trial data for inebilizumab, an IgG1 monoclonal antibody targeting CD19, in patients with ...

In 2015, non-gaming economic development activity was little more than a nascent idea for most of Michigan’s federally recognized Native American Tribes. However, just... Staying current is easy with ...